If Trump thinks he can make money by investing in Novartis and pumping a low margin commodity drug from its generic house, Sandoz, then he’s stupider than I even think.
Maybe the money trail is not showing so easily, on the surface. It's been shown here that Novartis was one of the main lobbyists and contributors to Trump, at the time of the Michael Cohen debacle. So we don't know what the deeper ties are. And we don't know what might be in the works for a new patent of a derivative.
Example: what is the very expensive drug Invega? Paliperidone. Now, what is paliperidone? It's a step ahead in the metabolism of risperidone.
Look at this. Here is the full chemical name/structure of paliperidone.
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one.
Its molecular formula is C23H27FN4O2.
Now let's see what risperidone is.
(±)-3-[2-[4-(6-fluoro-1,2-‑benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-
9-hydroxy-2-methyl-4H-‑pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O3.
What is common here?
Almost EVERYTHING!!! It's the 9-hydroxy form of the other one. It's an active metabolite of risperidone. Paliperidone is nothing other than 9-hydroxyrisperidone. Risperidone breaks into paliperidone in the body.
So, risperidone (brand name Risperdal) had its patent expired... became generic and became cheap. So what did Janssen do (the original makers of Risperidal)? They made paliperidone! Got a new patent.
Do you know how much a shot of Invega Sustenna costs, without insurance?
$2,521.99
No kidding.
So, don't count big pharma out, in terms of new uses, new FDA indications, and new (slightly modified) drugs for new patents, then becoming hugely profitable.